Tower Research Capital LLC (Trc) Gilead Sciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 109,283 shares of GILD stock, worth $12.2 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
109,283
Previous 38,411
184.51%
Holding current value
$12.2 Million
Previous $3.22 Million
213.58%
% of portfolio
0.21%
Previous 0.09%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
2,094Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.03 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.76 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.49 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $140B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...